Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Feline Leukemia Virus p27 Monoclonal Antibody (D67D)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA17466

Catalog No. PIMA17466


Only null left
Add to Cart

Description

Description

The MA1-7466 antibody reacts with Feline Leukemia virus FeLv p27 in viral and infected tissue samples. MA1-7466 has been successfully used in ELISA and Western blot applications. The MA1-7466 antibody was raised against FeLv p27 protein.

Feline leukemia virus (FeLV) is a retrovirus that infects cats. As a retrovirus, FeLV is transmitted as an RNA virus but the RNA is reverse transcribed into DNA. Retroviruses contradict the Central dogma of molecular biology. FeLV is usually transmitted between infected cats when the transfer of saliva or nasal secretions is involved. If not defeated by the animal's immune system, the virus can be lethal. The disease caused by this virus is a form of cancer of blood cells called lymphocytes (a leukemia).
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Feline Leukemia Virus p27
Monoclonal
0.1 mg/mL
PBS with 0.1% sodium azide; pH 7.2
Mouse
Protein A
RUO
Virus
Antibody
IgG2b
ELISA, Lateral Flow, Western Blot, Immunocytochemistry
D67D
Unconjugated
FLV; FLV p27
FeLv p27 protein.
100 μg
Primary
4°C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.